Infectious Disease 2: bacterial infections Flashcards
Antibiotics for surgical prophylaxis (non-colorectal)
cefazolin
alternatives: vancomycin, clindamycin
antibiotics for colorectal or intra-abdominal surgical prophylaxis
cefotetan cefoxitin Unasyn ertapenmen or metronidazole + (cefazolin or ceftriaxone)
meningitis treatment for neonates
ampicillin + cefotaxime + gentamicin
meningitis treatment for 1 mo to 50 years old
(cetriaxone or cefotaxime) & vancomycin
meningitis treatment for > 50 years old or immunocompromised any age
ampicillin + (cetriaxone or cefotaxime) + vancomycin
influenza treatment
oseltamivir x 5 days
zanamivir inhalation x 5 days
baloxavir x 1 dose
S. pyogenes treatment
penicillin x 10 days
amoxicillin x 10 days
azithromycin x 5 days
sinusitis treatment
Augmentin
ABECB treatment inclusion and preferred antibiotics
increased dyspnea, sputum volume and sputum purulence OR mechanically ventilated
Augmentin
azithromycin
doxycycline
Outpatient CAP treatment category 1 (no comorbidities)
HD amoxicillin (1 g TID) or
doxycycline or
macrolide (azithromycin or clarithromycin if resistance is <25%)
Outpatient CAP treatment category 2 (with comorbidities)
comorbidities include: chronic heart, liver, renal disease, DM, alcoholism, malignancy or asplenia
beta-lactam + (macrolide or doxycycline)
(Augmentin or cefpodoxime or cefdinir or
cefuroxime) & (macrolide or doxycycline)
monotherapy with respiratory quinolone: (moxifloxacin, gemifloxacin, levofloxacin)
Nonsevere non-ICU inpatient CAP treatment
(Similar to category 2)
beta-lactam + (macrolide or doxycycline)
(Augmentin or cefpodoxime or cefdinir or
cefuroxime) & (macrolide or doxycycline)
monotherapy with respiratory quinolone: (moxifloxacin, gemifloxacin, levofloxacin)
Severe inpatient CAP treatment
beta-lactam + macrolide
or
beta-lactam + respiratory quinalone
Onset of HAP
> 48 hours after admission
Onset of VAP
> 48 hours after the start of mechanical ventilation
HAP/VAP low risk for MRSA or MDR pathogens
1 antibiotic to cover Pseudomonas and MSSA
cefepime
Zosyn
HAP/VAP risk for MRSA but low risk for MDR pathogens
2 antibiotics combinations, one for MRSA and one for Pseudomonas
cefepime + vancomycin
meropenem + linezolid
HAP/VAP risk for both MRSA and MDR pathogens
3 antibiotic combination, one for MRSA and two for Pseudomonas
Zosyn + ciprofloxacin + vancomycin
cefepime + gentamicin + linezolid
Identifying risk for MRSA or MDR pathogens
positive MRSA nasal swab
high prevalence of resistant pathogens in hospital unit
IV abx use within the last 90 days
Preferred Latent TB therapy in adults, children > 2 yo and HIV+ patients
INH + rifapentine once weekly x 12 weeks (via DOT)
Preferred Latent TB therapy for children of all ages and HIV - patients
Rifampin 600 mg daily for 4 months
Preferred Latent TB therapy in adults and children of all ages and HIV + patients
Isoniazid with rifampin daily for 3 months
Latent TB treatment in pregnancy
INH for 9 months
Active tuberculosis treatment
Intensive phase: rifampin, isoniazid, pyrazinamide and ethambutol for 2 months
Continuation phase: rifampin and isoniazid for 4-7 months
rifampin
Side effects and notes
Increased LFT, hemolytic anemia (positive Coombs test) flu-like syndrome, orange-red discoloration of skin and body secretions
CYP3A4 inducer , may replace with rifabutin in some cases
isoniazid (INH)
concurrent adminstration, BW, SE
Adminster with pyridoxine (B6) 25-50 mg to decrease risk of induced peripheral neuropathy
BW: hepatitis
peripheral neuropathy
SE: increased LFT, DILE, hemolytic anemia (positive Coombs test)
pyrazinadmide
CI, SE
C/I acute gout
SE: increased LFT, hyperuricemia/gout
ethambutol SE
Increased LFT, optic neuritis, confusion, hallucinations
Increased LFT, optic neuritis, confusion, hallucinations
amoxicillin 2 grams 30-60 mins before procedure
alt: clinda 600 mg or azithro/clarthro 500 mg
Presentation and treatment: impetigo
honey-colored crusts
topical mupirocin
cephalexin 250 mg PO QID
treatment: follicuitits/furuncles/carbuncles
MSSA: cephalexin 500 mg PO QID
MRSA: SMX/TMP DS
doxycycline
treatment of non-purulent cellulitis
cephalexin 500 mg PO QID
treatment of purulent absess
SMX/TMP DS
Doxycycline
treatment for severe purulent SSTI
Vancomycin
daptomycin
linezolid
treatment for necrotizing fasclitis
vancomycin + (Zosyn, imipenem/cilastatin, or meropenem)
treatment for acute uncomplicated cystitis
nitrofurantoin 100 mg PO BID with food x 5 days
or
Bactrim DS 1 tab PO BID x 3 days
treatment for acute cystitis in pregnancy
cephalexin
amoxicilin
how long to treat asymptomatic pregnant women with cystitis
3-7 days
treatment for uncomplicated pyelonephritis
cipro
levo
ceftriaxone
bactrim
phenazopyridine use in UTI
relieve dysuria
treatment is 2 days max
take with 8oz of water after a meal
red-orange discoloration of urine and bodily fluids (harmless)
treatment for syphillis (< 1 year duration)
Bicillin L-A: 2.4 million units IM x1
treatment for late latent syphilis
Bicillin L-A: 2.4 million units IM weekly x 3 weeks
treatment for gonorrhea
ceftrixone 500 mg IM x1
and
azithromycin 1 g PO x1
(monotherapy is not recommended)
treatment for chlamydia
azithromycin 1 gram PO x1
treatment for bacterial vaginosis
metronidazole
trichomoniasis presentation
fishy frothy green/yellow discharge only in female anatomy
trichomoniasis treatment
metronidazole 2 grams PO x1
CDC recommendation for trichomoniasis treatment in pregnancy
metronidazole is recommended in all trimesters; despite it being C/I in the first trimester
treatment for HPV (genital warts)
imiquimod cream
which rickettsial diseases are treated with doxycycline?
Rocky mountain spotted fever
Typhus
Lyme disease
Ehrlichiosis